Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan/Cisplatin Induction and Concurrent Chemoradiotherapy in Stage III NSCLC
NCT00616785Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of irinotecan in non-small cell lung cancer (NSCLC), sponsored by Yonsei University. Status: unknown.
02
Drugs
irinotecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00616785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616785.